E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 4/9/2007 in the Prospect News PIPE Daily.

New Issue: Robcor settles $12.96 million tranche of $33 million stock sale

By Sheri Kasprzak

New York, April 9 - Robcor Properties, Inc. closed a $12.96 million tranche of its previously announced private placement, bringing the total proceeds raised in the offering to $32.96 million.

The company sold 16 million common shares at $0.81 apiece.

The investors also received warrants for 4 million shares, exercisable at $1.35 each.

In the first closing, which occurred March 13, the company sold 24,691,358 shares at $0.81 each.

National Securities Corp. and Brean Murray, Carret & Co. were the placement agents.

Proceeds will be used for research and development costs and working capital.

Cranbury, N.J.-based Robcor is the parent company of Redpoint Bio Corp., a biotechnology company that uses advanced technology to discover and develop novel taste enhancers for the food, beverage and pharmaceutical industries.

Issuer:Robcor Properties, Inc.
Issue:Stock
Amount:$12.96 million
Shares:16 million
Price:$0.81
Warrants:For 4 million shares
Warrant strike price:$1.35
Placement agents:National Securities Corp.; Brean Murray, Carret & Co.
Settlement date:April 6
Stock symbol:OTCBB: RBCR
Stock price:$3.00 at close April 6

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.